Tendarix.ca
BUSINESS NEWS
Storm Clouds Continue to Gather Over Canada’s Economy· EnergyNowOpinion: Mark Carney’s climate ambitions still threaten Canada’s economy· Financial PostQ3-26 Canadian Business Outlook Survey: More firms plan cost pass-through· RBCA new chapter in Canada-India economic relations· Business Council of CanadaStaying in Canada is a 'huge relief' for Alberta business leaders· CBCTrump administration cancels some Canada tariffs amid close midterm races· NBC NewsWhat Canadian Businesses Must Embrace to Compete in a Volatile Global Economy· Open CanadaCarney, Erdogan launch ‘strong and resilient’ Canada-Turkiye partnership· Al JazeeraJapan-Canada Chambers Council Joint Statement· Canadian Chamber of CommerceGlobal trade is changing how the Canadian economy works· Bank of CanadaEastern Canada business leaders call for ‘single economy’ between Atlantic provinces· Global NewsSoft economy should limit Bank of Canada's rate hikes: Capital Economics· BNN BloombergCanada’s services PMI shows sector shrinking for fourth straight month in September· The Globe and MailCanada’s inflation data, business survey on tap ahead of BoC decision· RBCPosthaste: U.S. businesses feel fresh pain from trade war with Canada, says this hot take on the economy· Financial Post
← All tenders
Health Canada

Essais de toxicité cellulaire in vitro sur des dispositifs de vapotage et de tabac chauffé

Request for Proposal (RFP)
Estimated value
Not disclosed
Deadline
February 6, 2019
Published
December 21, 2018
Type
Services
Explore similarOntario

Full description

This Request for Proposal (RFP) is split into two (2) streams. Stream 1: In vitro testing of vaping liquids and vaping liquid ingredients; and, Stream 2: In vitro air-liquid-interface testing of alternative product emissions. Work for each stream will be performed on an "as and when requested basis" using a Task Authorization (TA) process.
Bidders must submit separate bids if bidding on both streams.
Multiple contracts may be awarded in each Stream in order to meet requirements. For Stream 1, the Bidder must bid on Task A and at least one (1) Optional Task (B, C, D, E or F) and be compliant with all mandatory requirements in the RFP in order to be awarded a contract. For Stream 2, the Bidder must bid on Task 1 & 2 and be compliant with all mandatory requirements in the RFP in order to be awarded a contract.
The services of the Contractor will be required for a period of approximately 12 months commencing on or about April 1st, 2019. The expected completion date of this project is the 31st of March, 2020. The Contract will be set up with the option of annual renewal up to a maximum of three (3) one (1) year renewals (option year 1: April 2020-March 2021; option year 2: April 2021-March 2022; option year 3: April 2022-March 2023) to be exercised at Health Canada’s discretion. Should option year(s) be exercised, the expected completion date for option year one is the 31st of March, 2021; option year two is the 31st of March, 2022; and option year three is the 31st of March, 2023.
There are no security requirements associated with this requirement.
The requirement is subject to the provisions of the World Trade Organization Agreement on Government Procurement (WTO-AGP), the North American Free Trade Agreement (NAFTA), the Canada-European Union Comprehensive Economic and Trade Agreement (CETA), and the Canadian Free Trade Agreement (CFTA)
Stream 1: In vitro testing of vaping liquids and vaping liquid ingredients
Health Canada requires the services of a Contractor to conduct in vitro toxicity testing of identified chemicals and vaping liquid samples in support of research activities at the Tobacco Control Directorate (TCD) on an "as and when requested basis" using a Task Authorization (TA) process. A minimum of one (1) Project Manager and one (1) Laboratory Technician are required. Work is to be completed at the Contractor’s place of business.
Stream 2: In vitro air-liquid-interface testing of alternative product emissions
Health Canada requires the services of a Contractor to conduct in vitro toxicity testing of emission from conventional or alternative devices at the air-liquid interface (ALI) in support of research activities at the Tobacco Control Directorate (TCD) on an "as and when requested basis" using a Task Authorization (TA) process. A minimum of one (1) Project Manager and one (1) Laboratory Technician are required. Work is to be completed at the Contractor’s place of business.

AI Analysis

Get a plain-English breakdown of this tender — what they need, who can bid, how to approach it, and tips for small suppliers. Takes a couple of seconds.

Basic information

Reference
PW-18-00857132
Solicitation no.
1000203303A
Buyer
Health Canada
Notice type
Request for Proposal
Method
Competitive - Open bidding
Procurement category
*SRV
Trade agreements
*World Trade Organization Agreement on Government Procurement (WTO GPA) *Canada-European Union Comprehensive Economic and Trade Agreement (CETA) *Canadian Free Trade Agreement (CFTA) *North American Free Trade Agreement (NAFTA)
Estimated value
Not disclosed
Source
canadabuys

Classification & terms

GSIN
*AN117500 *AZ110112 *B000A *B503A — *Medical (R&D) *Scientific Data Collection - Other Than Field (R&D) *Chemical/Biological Studies and Analyses, Military *Medical and Health Studies

Delivery & regions

Province
Ontario
Regions of delivery
*National Capital Region (NCR)

Key dates

Published
December 21, 2018
Closes
February 6, 2019
Amendment no.
006

Contact

End-user
Health Canada
Sign up free to see the contact details

Live tenders

Royal Canadian Navy (RCN)Closing today

Furniture Installation

Indigenous set-asideGoods
75 MATCHView →
Department of National Defence (DND)1 day left

4 X Winter Loaders Rental

Services
78 MATCHView →
Department of Public Works and Government Services (PSPC)1 day left

Solicitation of Offers – FR-EN Translation Services - General and Administrative Texts Field- Tier 2

Services
79 MATCHView →